Efficacy of a bivalent HPV 16/18 vaccine against anal HPV16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial

BACKGROUND: Anal cancer remains rare (incidence of ∼1.5 per 100,000 women annually) but rates are increasing in many countries. Human papillomavirus-16 (HPV16) infection causes most cases. We evaluated vaccine efficacy (VE) of an ASO4-adjuvanted HPV16/18 vaccine against anal HPV16/18 infection. METH...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kreimer, Aimée R., Gonzalèz, Paula, Katki, Hormuzd A., Porras, Carolina, Schiffman, Mark, Rodriguez, Ana Cecilia, Solomon, Diane, Jimenez, Silvia, Schiller, John T., Lowy, Douglas R., van Doorn, Leen-Jan, Struijk, Linda, Quint, Wim, Chen, Sabrina, Wacholder, Sholom, Hildesheim, Allan, Herrero, Rolando
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3172992/
https://ncbi.nlm.nih.gov/pubmed/21865087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(11)70213-3
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge